This site is intended for healthcare professionals
Blue test tubes arranged in a line, disappearing into the background
  • Home
  • /
  • News
  • /
  • 2018
  • /
  • 04
  • /
  • FDA 510 (k) approval for Velocity cancer imaging s...
Drug news

FDA 510 (k) approval for Velocity cancer imaging software for Y90 Selective Internal Radiation Therapy (SIRT) dosimetry analysis.- Varian Medical.

Read time: 1 mins
Last updated: 11th Apr 2018
Published: 11th Apr 2018
Source: Pharmawand

Varian Medical announced a new version of its Velocity cancer imaging software which includes Rapidsphere , a module for Y90 Selective Internal Radiation Therapy (SIRT) dosimetry analysis. Rapidsphere provides the ability for cancer care teams to better understand tumor response and normal-tissue toxicity for individual patients receiving SIRT. This new software module extends Varian's Velocity software to interventional radiologists for use in targeted cancer therapy delivery to patients with liver malignancies. Velocity 4.0 and the Rapidsphere module have received FDA 510(k) clearance.

How do you prefer to access medical updates and information?

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.